Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

UK research unveils new generation of immunological adjuvants

13.08.2002


Investment from the White Rose Technology Seedcorn Fund (WRTSF) - the venture capital fund owned by the universities of Leeds, Sheffield and York (UK) - has funded the completion of a series of significant technical milestones in the development of a new family of `immunologically-rational` adjuvants for vaccines, which are materially very different from the existing adjuvants based on aluminium salts and bacterial cell wall components.



Sheffield-based life science company Adjuvantix Ltd is now well positioned in its ambition to enter the $5 billion vaccine market(i).

The patented technology produces adjuvants that have greater effectiveness and no harmful side effects - addressing the key hurdles(ii) that have been preventing the development of vaccines for the infectious diseases such as hepatitis-B, hepatitis-C and HIV. Moreover the novel adjuvants should enable a new generation of therapeutic and prophylactic vaccines for chronic, non-infectious diseases such as diabetes, multiple sclerosis and stroke.


The company is based on the research in the University of Sheffield`s Department of Genomic Medicine and has already attracted significant interest from a number of pharmaceutical companies.

Dr. Peter Laing, formerly Research Director at Actinova Ltd and SynGenix Ltd has been appointed as a non-executive director to the company, and David Gough, formerly Chief Executive of Avlar BioVentures has been appointed as consultant to the management team in preparation for the next round of funding.

Peter Laing said
"The Adjuvantix technology is extremely exciting and will be a key enabler in the race to develop new vaccines based upon developments in genomics. "

The company is currently focusing on developing adjuvants for vaccines to prevent and treat Alzheimer`s disease, influenza, meningitis and herpes virus infection - each chosen to represent a specific area of Adjuvantix expertise.

David Gough | alfa

More articles from Health and Medicine:

nachricht Study tracks inner workings of the brain with new biosensor
16.08.2018 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht Foods of the future
15.08.2018 | Georg-August-Universität Göttingen

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Color effects from transparent 3D-printed nanostructures

New design tool automatically creates nanostructure 3D-print templates for user-given colors
Scientists present work at prestigious SIGGRAPH conference

Most of the objects we see are colored by pigments, but using pigments has disadvantages: such colors can fade, industrial pigments are often toxic, and...

Im Focus: Unraveling the nature of 'whistlers' from space in the lab

A new study sheds light on how ultralow frequency radio waves and plasmas interact

Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

LaserForum 2018 deals with 3D production of components

17.08.2018 | Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

 
Latest News

Climate Impact Research in Hannover: Small Plants against Large Waves

17.08.2018 | Life Sciences

LaserForum 2018 deals with 3D production of components

17.08.2018 | Event News

Quantum material is promising 'ion conductor' for research, new technologies

17.08.2018 | Materials Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>